Dan Jacob Gelvan
Chief Executive Officer of Ag Plenus Ltd.Dr. Dan Jacob Gelvan, Ph.D., has been Chief Executive Officer of Ag Plenus Ltd. at Evogene Ltd. since February 19, 2024. He served as the Managing Director of Life Sciences at Aurum Ventures MKI Ltd. Dr. Gelvan is an experienced lecturer of corporate finance and entrepreneurship. He is an experienced life science executive who has unique combination of operational and strategic management. He was Executive Vice President of PolyPid Ltd. Dr. Gelvan served as the Chief Executive Officer of Gammacan, Ltd. He founded Zetiq Technologies Ltd and serves as its Chief Executive Officer and President. Prior to founding Zetiq, he held a number of strategic and business development positions at Clal (Israel) Ltd. He served as Advisor of GammaCan International Inc. since July 2, 2005. He serves as Chairman of the Board for CorAssist Cardiovascular Ltd. and Beta-O2 Technologies Ltd. He serves as Chairman of Vecta Ltd. He has been a Director of LifeBond Ltd. since May 23, 2011. He serves as a Director of FertiSeeds Ltd and IntelliDx, Inc. He served as a Director of PolyPid Ltd. until January 9, 2017. He served as a Non-Executive Director of Vascular Biogenics Ltd. from Jul 2005 to November 6, 2016. He served as Director at Zetiq Technologies LTD. Dr. Gelvan holds a Ph.D. in Business Economics from Roskilde University in Denmark as well as a B.A. degree and a M.A. degree, cum laude in Economics from the Hebrew University of Jerusalem.
Positions
- Company NameEvogene Ltd.Stock CodeEVGNPositionChief Executive Officer of Ag Plenus Ltd.Colleagues
- OHOfer HavivCEO, President, CFO & Director
- AZAdi Zuluf-ShaniChairman
- YZYoash ZoharChief Executive Officer of Casterra Ag Ltd.
- IZIlia ZhidkovChief Technology Officer
- LFLiat Foigel WejgmanVice President of Human Resources
- DFDan FalkIndependent Director
- LYLeon Y. RecanatiIndependent Director
- SWSarit Weiss-FironIndependent Director
